These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population]. Zhai ZG, Wang C, Yang YH, Pang BS, Xiao B, Liu YM, Mao YL, Weng XZ. Zhonghua Yi Xue Za Zhi; 2006 May 23; 86(19):1313-7. PubMed ID: 16796899 [Abstract] [Full Text] [Related]
3. [Relationship between PAI-1 gene 4G/5G polymorphism and clinical profile of IgA nephropathy]. Ding R, Chen XM, Liu SW, Lv Y, Wu J. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug 23; 23(4):449-51. PubMed ID: 16883539 [Abstract] [Full Text] [Related]
4. Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome. Luo Y, Wang C, Tu H. Mol Med Rep; 2014 Mar 23; 9(3):894-8. PubMed ID: 24435552 [Abstract] [Full Text] [Related]
5. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect]. Gong R, Liu Z, Chen Z, Li L. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb 23; 19(1):1-5. PubMed ID: 11836675 [Abstract] [Full Text] [Related]
6. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis. Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G. J Clin Periodontol; 2007 Apr 23; 34(4):278-84. PubMed ID: 17257155 [Abstract] [Full Text] [Related]
7. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY. Diabetes Metab; 2009 Jun 23; 35(3):214-9. PubMed ID: 19419896 [Abstract] [Full Text] [Related]
8. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease. Gardemann A, Lohre J, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W. Thromb Haemost; 1999 Sep 23; 82(3):1121-6. PubMed ID: 10494775 [Abstract] [Full Text] [Related]
9. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer. Smolarz B, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Szewczyk T. J Exp Clin Cancer Res; 2001 Jun 23; 20(2):247-52. PubMed ID: 11484982 [Abstract] [Full Text] [Related]
10. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity. Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A. Thromb Res; 2006 Jun 23; 117(5):487-92. PubMed ID: 15907980 [Abstract] [Full Text] [Related]
11. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province]. Liu SQ, Xue YM, Yang GC, He FY, Zhao XS. Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug 23; 24(8):904-7. PubMed ID: 15321757 [Abstract] [Full Text] [Related]
12. Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1. Bergheanu SC, Pons D, Jukema JW, van der Hoeven BL, Liem SS, Vandenbroucke JP, Rosendaal FR, le Cessie S, Schalij MJ, van der Bom JG. Chronobiol Int; 2009 May 23; 26(4):637-52. PubMed ID: 19444746 [Abstract] [Full Text] [Related]
13. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion]. Guan LX, Du XY, Wang JX, Gao L, Wang RL, Li HB, Wang SX. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun 23; 22(3):330-3. PubMed ID: 15952129 [Abstract] [Full Text] [Related]
14. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome]. Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr 23; 21(2):173-5. PubMed ID: 15079805 [Abstract] [Full Text] [Related]
15. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer. Eroglu A, Ulu A, Cam R, Akar N. J BUON; 2006 Apr 23; 11(4):481-4. PubMed ID: 17309181 [Abstract] [Full Text] [Related]
16. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis. Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A. J Periodontol; 2007 Jul 23; 78(7):1256-63. PubMed ID: 17608581 [Abstract] [Full Text] [Related]
17. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome. Glueck CJ, Sieve L, Zhu B, Wang P. Metabolism; 2006 Mar 23; 55(3):345-52. PubMed ID: 16483878 [Abstract] [Full Text] [Related]
18. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels. Kathiresan S, Gabriel SB, Yang Q, Lochner AL, Larson MG, Levy D, Tofler GH, Hirschhorn JN, O'Donnell CJ. Circulation; 2005 Sep 20; 112(12):1728-35. PubMed ID: 16172282 [Abstract] [Full Text] [Related]
19. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease]. Zhang AY, Ji XW, Guan LX. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr 20; 25(2):233-5. PubMed ID: 18393255 [Abstract] [Full Text] [Related]
20. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia]. Nowakowska A. Ann Acad Med Stetin; 2005 Apr 20; 51(1):95-105. PubMed ID: 16496609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]